These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35776385)

  • 1. Customized 3D-printed hollow capsular device filled with norfloxacin-loaded micropellets for controlled-release delivery.
    Suryavanshi P; Chaudhari VS; Banerjee S
    Drug Deliv Transl Res; 2023 May; 13(5):1183-1194. PubMed ID: 35776385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vitro and In Vivo Evaluations of Berberine-Loaded Microparticles Filled In-House 3D Printed Hollow Capsular Device for Improved Oral Bioavailability.
    Choudhury D; Jala A; Murty US; Borkar RM; Banerjee S
    AAPS PharmSciTech; 2022 Mar; 23(4):89. PubMed ID: 35296955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of 3D printing technologies and compressed tablets for preparation of riboflavin floating tablet-in-device (TiD) systems.
    Fu J; Yin H; Yu X; Xie C; Jiang H; Jin Y; Sheng F
    Int J Pharm; 2018 Oct; 549(1-2):370-379. PubMed ID: 30107218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preparation and
    Kaidierya A; Zhang RG; Qian HN; Zou ZY; Danniya Y; Fan TY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 54(6):1202-1207. PubMed ID: 36533356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3D-Printed Network Structures as Controlled-Release Drug Delivery Systems: Dose Adjustment, API Release Analysis and Prediction.
    Korte C; Quodbach J
    AAPS PharmSciTech; 2018 Nov; 19(8):3333-3342. PubMed ID: 29855799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3D-Printed Isoniazid Tablets for the Treatment and Prevention of Tuberculosis-Personalized Dosing and Drug Release.
    Öblom H; Zhang J; Pimparade M; Speer I; Preis M; Repka M; Sandler N
    AAPS PharmSciTech; 2019 Jan; 20(2):52. PubMed ID: 30617660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereolithographic (SLA) 3D printing of oral modified-release dosage forms.
    Wang J; Goyanes A; Gaisford S; Basit AW
    Int J Pharm; 2016 Apr; 503(1-2):207-12. PubMed ID: 26976500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3D scanning and 3D printing as innovative technologies for fabricating personalized topical drug delivery systems.
    Goyanes A; Det-Amornrat U; Wang J; Basit AW; Gaisford S
    J Control Release; 2016 Jul; 234():41-8. PubMed ID: 27189134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extrusion 3D printing of minicaplets for evaluating in vitro & in vivo praziquantel delivery capability.
    Bhatt U; Jorvekar SB; Suryanarayana Murty U; Borkar RM; Banerjee S
    Int J Pharm; 2023 Jan; 630():122445. PubMed ID: 36503849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 3D printed bilayer oral solid dosage form combining metformin for prolonged and glimepiride for immediate drug delivery.
    Gioumouxouzis CI; Baklavaridis A; Katsamenis OL; Markopoulou CK; Bouropoulos N; Tzetzis D; Fatouros DG
    Eur J Pharm Sci; 2018 Jul; 120():40-52. PubMed ID: 29678613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereolithography (SLA) 3D printing of ascorbic acid loaded hydrogels: A controlled release study.
    Karakurt I; Aydoğdu A; Çıkrıkcı S; Orozco J; Lin L
    Int J Pharm; 2020 Jun; 584():119428. PubMed ID: 32445906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coupling 3D printing with hot-melt extrusion to produce controlled-release tablets.
    Zhang J; Feng X; Patil H; Tiwari RV; Repka MA
    Int J Pharm; 2017 Mar; 519(1-2):186-197. PubMed ID: 28017768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3D printing: An appealing route for customized drug delivery systems.
    Elkasabgy NA; Mahmoud AA; Maged A
    Int J Pharm; 2020 Oct; 588():119732. PubMed ID: 32768528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral drug delivery systems using core-shell structure additive manufacturing technologies: a proof-of-concept study.
    Zhang J; Xu P; Vo AQ; Repka MA
    J Pharm Pharmacol; 2021 Mar; 73(2):152-160. PubMed ID: 33793804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereolithography 3D printing technology in pharmaceuticals: a review.
    Deshmane S; Kendre P; Mahajan H; Jain S
    Drug Dev Ind Pharm; 2021 Sep; 47(9):1362-1372. PubMed ID: 34663145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3D printing of PVA capsular devices for modified drug delivery: design and in vitro dissolution studies.
    Cotabarren I; Gallo L
    Drug Dev Ind Pharm; 2020 Sep; 46(9):1416-1426. PubMed ID: 32619117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled Release of 5-Fluorouracil from Alginate Beads Encapsulated in 3D Printed pH-Responsive Solid Dosage Forms.
    Gioumouxouzis CI; Chatzitaki AT; Karavasili C; Katsamenis OL; Tzetzis D; Mystiridou E; Bouropoulos N; Fatouros DG
    AAPS PharmSciTech; 2018 Nov; 19(8):3362-3375. PubMed ID: 29948989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D Printed Intragastric Floating and Sustained-Release Tablets with Air Chambers.
    Zhao X; Wei W; Niu R; Li Q; Hu C; Jiang S
    J Pharm Sci; 2022 Jan; 111(1):116-123. PubMed ID: 34303671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of 3D DLP Printed Sustained Release Ibuprofen Tablets and Their Pharmacokinetic Evaluation in Rats.
    Mosley-Kellum K; Bagde A; Spencer S; Dev S; Singh M
    AAPS PharmSciTech; 2023 Mar; 24(4):88. PubMed ID: 36977867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and investigation of controlled-release glipizide novel oral device with three-dimensional printing.
    Li Q; Wen H; Jia D; Guan X; Pan H; Yang Y; Yu S; Zhu Z; Xiang R; Pan W
    Int J Pharm; 2017 Jun; 525(1):5-11. PubMed ID: 28377316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.